{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:47:57Z","timestamp":1777855677929,"version":"3.51.4"},"reference-count":51,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"The Qiqihar City Joint Guidance Project for Science and Technology Planning","award":["LSFGG-2024050"],"award-info":[{"award-number":["LSFGG-2024050"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Am J Mens Health"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:p>This study systematically investigates the prognostic value and clinical significance of PANoptosis-related genes in bladder cancer (BC). By integrating the TCGA and GEO databases, two PANoptosis molecular subtypes with significant survival differences were identified, with the C2 subtype demonstrating a more favorable prognosis. A prognostic model comprising nine key genes was constructed, demonstrating robust risk stratification capabilities in both training and validation sets. Further analysis revealed that high-risk patients exhibited distinct immunosuppressive microenvironment characteristics, including enrichment of Treg cells and M2 macrophages. Single-cell sequencing analysis elucidated the cell-type-specific expression patterns of these genes within the tumor microenvironment. Experimental validation confirmed the significant overexpression of KCNJ15, FASN, and ADAMTS12 in BC tissues. The prognostic model established in this study provides a novel tool for risk stratification of BC patients while simultaneously establishing the foundation for in-depth exploration of PANoptosis mechanisms in BC.<\/jats:p>","DOI":"10.1177\/15579883251404985","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T09:34:52Z","timestamp":1766741692000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploration of the Prognostic Value of PANoptosis-Related Genes in Bladder Cancer"],"prefix":"10.1177","volume":"19","author":[{"given":"Jichao","family":"Tan","sequence":"first","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Qiqihar Medical University, Qiqihar, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanjue","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Qiqihar Medical University, Qiqihar, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Qiqihar Medical University, Qiqihar, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Qiqihar Medical University, Qiqihar, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Qiqihar Medical University, Qiqihar, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Qiqihar Medical University, Qiqihar, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuncheng","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Qiqihar Medical University, Qiqihar, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7679-8335","authenticated-orcid":false,"given":"Lihe","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Qiqihar Medical University, Qiqihar, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,12,26]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"crossref","unstructured":"Ascione C. M. Napolitano F. Esposito D. Servetto A. Belli S. Santaniello A. Formisano L. (2023). Role of FGFR3 in bladder cancer: Treatment landscape and future challenges. Cancer Treatment Reviews 115 102530. https:\/\/doi.org\/10.1016\/j.ctrv.2023.102530","DOI":"10.1016\/j.ctrv.2023.102530"},{"key":"e_1_3_2_3_1","doi-asserted-by":"crossref","unstructured":"Awasthi S. Kumar R. Pradhan D. Rawal N. Goel H. Sahu P. Tanwar P. (2024). Genomic landscape of gallbladder cancer: Insights from whole exome sequencing. International Journal of Surgery 110(11) 6883\u20136897. https:\/\/doi.org\/10.1097\/JS9.0000000000002031","DOI":"10.1097\/JS9.0000000000002031"},{"key":"e_1_3_2_4_1","doi-asserted-by":"crossref","unstructured":"Ayers M. Lunceford J. Nebozhyn M. Murphy E. Loboda A. Kaufman D. R. McClanahan T. K. (2017). IFN-gamma-related mRNA profile predicts clinical response to PD-1 blockade. Journal of Clinical Investigation 127(8) 2930\u20132940. https:\/\/doi.org\/10.1172\/JCI91190","DOI":"10.1172\/JCI91190"},{"key":"e_1_3_2_5_1","doi-asserted-by":"crossref","unstructured":"Bhanvadia S. K. (2018). Bladder cancer survivorship. Current Urology Reports 19(12) 111. https:\/\/doi.org\/10.1007\/s11934-018-0860-6","DOI":"10.1007\/s11934-018-0860-6"},{"key":"e_1_3_2_6_1","doi-asserted-by":"crossref","unstructured":"Cao G. Xuan X. Li Y. Hu J. Zhang R. Jin H. Dong H. (2023). Single-cell RNA sequencing reveals the vascular smooth muscle cell phenotypic landscape in aortic aneurysm. Cell Communication and Signaling 21(1) 113. https:\/\/doi.org\/10.1186\/s12964-023-01120-5","DOI":"10.1186\/s12964-023-01120-5"},{"key":"e_1_3_2_7_1","doi-asserted-by":"crossref","unstructured":"Chen Y. Chen L. Lun A. T. L. Baldoni P. L. Smyth G. K. (2025). edgeR v4: Powerful differential analysis of sequencing data with expanded functionality and improved support for small counts and larger datasets. Nucleic Acids Research 53(2). https:\/\/doi.org\/10.1093\/nar\/gkaf018","DOI":"10.1093\/nar\/gkaf018"},{"key":"e_1_3_2_8_1","doi-asserted-by":"crossref","unstructured":"Damotte D. Warren S. Arrondeau J. Boudou-Rouquette P. Mansuet-Lupo A. Biton J. Leroy K. (2019). The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort. Journal of Translational Medicine 17(1) 357. https:\/\/doi.org\/10.1186\/s12967-019-2100-3","DOI":"10.1186\/s12967-019-2100-3"},{"key":"e_1_3_2_9_1","doi-asserted-by":"crossref","unstructured":"Davidovich P. Higgins C. A. Najda Z. Longley D. B. Martin S. J. (2023). CFLIP(L) acts as a suppressor of TRAIL- and Fas-initiated inflammation by inhibiting assembly of caspase-8\/FADD\/RIPK1 NF-kappaB-activating complexes. Cell Reports 42(12) 113476. https:\/\/doi.org\/10.1016\/j.celrep.2023.113476","DOI":"10.1016\/j.celrep.2023.113476"},{"key":"e_1_3_2_10_1","doi-asserted-by":"crossref","unstructured":"Dawoodi S. Rizvi S. A. A. Zaidi A. K. (2024). Innate immune responses to SARS-CoV-2. Progress in Molecular Biology and Translational Science 202 127\u2013154. https:\/\/doi.org\/10.1016\/bs.pmbts.2023.11.003","DOI":"10.1016\/bs.pmbts.2023.11.003"},{"key":"e_1_3_2_11_1","doi-asserted-by":"crossref","unstructured":"Gitlin A. D. Heger K. Schubert A. F. Reja R. Yan D. Pham V. C. Dixit V. M. (2020). Integration of innate immune signalling by caspase-8 cleavage of N4BP1. Nature 587(7833) 275\u2013280. https:\/\/doi.org\/10.1038\/s41586-020-2796-5","DOI":"10.1038\/s41586-020-2796-5"},{"key":"e_1_3_2_12_1","doi-asserted-by":"crossref","unstructured":"Jiang Z. Wang J. Dao C. Zhu M. Li Y. Liu F. Pan Z. (2024). Utilizing a novel model of PANoptosis-related genes for enhanced prognosis and immune status prediction in kidney renal clear cell carcinoma. Apoptosis 29(5\u20136) 681\u2013692. https:\/\/doi.org\/10.1007\/s10495-023-01932-3","DOI":"10.1007\/s10495-023-01932-3"},{"key":"e_1_3_2_13_1","doi-asserted-by":"crossref","unstructured":"Jozwicki W. Brozyna A. A. Siekiera J. Slominski A. T. (2016). Frequency of CD4+CD25+Foxp3+ cells in peripheral blood in relation to urinary bladder cancer malignancy indicators before and after surgical removal. Oncotarget 7(10) 11450\u201311462. https:\/\/doi.org\/10.18632\/oncotarget.7199","DOI":"10.18632\/oncotarget.7199"},{"key":"e_1_3_2_14_1","doi-asserted-by":"crossref","unstructured":"Kamat A. M. Hahn N. M. Efstathiou J. A. Lerner S. P. Malmstrom P. U. Choi W. Kassouf W. (2016). Bladder cancer. The Lancet 388(10061) 2796\u20132810. https:\/\/doi.org\/10.1016\/S0140-6736(16)30512-8","DOI":"10.1016\/S0140-6736(16)30512-8"},{"key":"e_1_3_2_15_1","doi-asserted-by":"crossref","unstructured":"Konala V. M. Adapa S. Aronow W. S. (2022). Immunotherapy in bladder cancer. American Journal of Therapeutics 29(3) e334\u2013e337. https:\/\/doi.org\/10.1097\/MJT.0000000000000934","DOI":"10.1097\/MJT.0000000000000934"},{"key":"e_1_3_2_16_1","doi-asserted-by":"crossref","unstructured":"Langfelder P. Horvath S. (2008). WGCNA: An R package for weighted correlation network analysis. BMC Bioinformatics 9 559. https:\/\/doi.org\/10.1186\/1471-2105-9-559","DOI":"10.1186\/1471-2105-9-559"},{"key":"e_1_3_2_17_1","doi-asserted-by":"crossref","unstructured":"Lenis A. T. Lec P. M. Chamie K. Mshs M. D. (2020). Bladder cancer: A review. Journal of the American Medical Association 324(19) 1980\u20131991. https:\/\/doi.org\/10.1001\/jama.2020.17598","DOI":"10.1001\/jama.2020.17598"},{"key":"e_1_3_2_18_1","doi-asserted-by":"crossref","unstructured":"Li K. Wei M. Zhang D. Zhai S. Liu H. (2024). PANoptosis in vascular smooth muscle cells regulated by TNF-alpha\/IL-1beta can be a new target for alleviating the progression of abdominal aortic aneurysm. Physiological Genomics 56(2) 158\u2013166. https:\/\/doi.org\/10.1152\/physiolgenomics.00053.2023","DOI":"10.1152\/physiolgenomics.00053.2023"},{"key":"e_1_3_2_19_1","doi-asserted-by":"crossref","unstructured":"Li R. Hensley P. J. Gupta S. Al-Ahmadie H. Babjuk M. Black P. C. Kamat A. M. (2024). Bladder-sparing therapy for Bacillus Calmette\u2013Gu\u00e9rin-unresponsive non-muscle-invasive bladder cancer: International Bladder Cancer Group recommendations for optimal sequencing and patient selection. European Urology 86(6) 516\u2013527. https:\/\/doi.org\/10.1016\/j.eururo.2024.08.001","DOI":"10.1016\/j.eururo.2024.08.001"},{"key":"e_1_3_2_20_1","doi-asserted-by":"crossref","unstructured":"Li Y. Wu D. (2024). Identification of signature genes and immune infiltration analysis in thyroid cancer based on PANoptosis related genes. Frontiers in Endocrinology 15 1397794. https:\/\/doi.org\/10.3389\/fendo.2024.1397794","DOI":"10.3389\/fendo.2024.1397794"},{"key":"e_1_3_2_21_1","doi-asserted-by":"crossref","unstructured":"Lin J. F. Hu P. S. Wang Y. Y. Tan Y. T. Yu K. Liao K. Qiu M. Z. (2022). Phosphorylated NFS1 weakens oxaliplatin-based chemosensitivity of colorectal cancer by preventing PANoptosis. Signal Transduction and Targeted Therapy 7(1) 54. https:\/\/doi.org\/10.1038\/s41392-022-00889-0","DOI":"10.1038\/s41392-022-00889-0"},{"key":"e_1_3_2_22_1","doi-asserted-by":"crossref","unstructured":"Lopez-Beltran A. Cookson M. S. Guercio B. J. Cheng L. (2024). Advances in diagnosis and treatment of bladder cancer. British Medical Journal 384 e076743. https:\/\/doi.org\/10.1136\/bmj-2023-076743","DOI":"10.1136\/bmj-2023-076743"},{"key":"e_1_3_2_23_1","doi-asserted-by":"crossref","unstructured":"Nie S. Huili Y. He Y. Hu J. Kang S. Cao F. (2022). Identification of bladder cancer subtypes based on necroptosis-related genes and construction of a prognostic model. Frontiers in Surgery 9 860857. https:\/\/doi.org\/10.3389\/fsurg.2022.860857","DOI":"10.3389\/fsurg.2022.860857"},{"key":"e_1_3_2_24_1","doi-asserted-by":"crossref","unstructured":"Ocansey D. K. W. Qian F. Cai P. Ocansey S. Amoah S. Qian Y. Mao F. (2024). Current evidence and therapeutic implication of PANoptosis in cancer. Theranostics 14(2) 640\u2013661. https:\/\/doi.org\/10.7150\/thno.91814","DOI":"10.7150\/thno.91814"},{"key":"e_1_3_2_25_1","doi-asserted-by":"crossref","unstructured":"Patel V. G. Oh W. K. Galsky M. D. (2020). Treatment of muscle-invasive and advanced bladder cancer in 2020. CA: A Cancer Journal for Clinicians 70(5) 404\u2013423. https:\/\/doi.org\/10.3322\/caac.21631","DOI":"10.3322\/caac.21631"},{"key":"e_1_3_2_26_1","doi-asserted-by":"crossref","unstructured":"Peng F. Liao M. Qin R. Zhu S. Peng C. Fu L. Han B. (2022). Regulated cell death (RCD) in cancer: Key pathways and targeted therapies. Signal Transduction and Targeted Therapy 7(1) 286. https:\/\/doi.org\/10.1038\/s41392-022-01110-y","DOI":"10.1038\/s41392-022-01110-y"},{"key":"e_1_3_2_27_1","doi-asserted-by":"crossref","unstructured":"Peng R. Ma X. Jiang Z. Duan Y. Lv S. Jing W. (2024). Integrative analysis of anoikis-related genes reveals that FASN is a novel prognostic biomarker and promotes the malignancy of bladder cancer via Wnt\/\u03b2-catenin pathway. Heliyon 10(13) e34029. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34029","DOI":"10.1016\/j.heliyon.2024.e34029"},{"key":"e_1_3_2_28_1","doi-asserted-by":"crossref","unstructured":"Peng W. Yang Y. Lu H. Shi H. Jiang L. Liao X. Liu J. (2024). Network pharmacology combines machine learning molecular simulation dynamics and experimental validation to explore the mechanism of acetylbinankadsurin A in the treatment of liver fibrosis. Journal of Ethnopharmacology 323 117682. https:\/\/doi.org\/10.1016\/j.jep.2023.117682","DOI":"10.1016\/j.jep.2023.117682"},{"key":"e_1_3_2_29_1","doi-asserted-by":"crossref","unstructured":"Pettenati C. Ingersoll M. A. (2018). Mechanisms of BCG immunotherapy and its outlook for bladder cancer. Nature Reviews Urology 15(10) 615\u2013625. https:\/\/doi.org\/10.1038\/s41585-018-0055-4","DOI":"10.1038\/s41585-018-0055-4"},{"key":"e_1_3_2_30_1","doi-asserted-by":"crossref","unstructured":"Pilchowski R. Stohr R. von Eggeling F. Hartmann A. Wunderlich H. Junker K. (2011). Specific protein patterns characterize metastatic potential of advanced bladder cancer. The Journal of Urology 186(2) 713\u2013720. https:\/\/doi.org\/10.1016\/j.juro.2011.03.124","DOI":"10.1016\/j.juro.2011.03.124"},{"key":"e_1_3_2_31_1","doi-asserted-by":"crossref","unstructured":"Qi D. Lu Y. Qu H. Dong Y. Jin Q. Sun M. Quan C. (2024). Independent prognostic value of CLDN6 in bladder cancer based on M2 macrophage-related signature. iScience 27(3) 109138. https:\/\/doi.org\/10.1016\/j.isci.2024.109138","DOI":"10.1016\/j.isci.2024.109138"},{"key":"e_1_3_2_32_1","doi-asserted-by":"crossref","unstructured":"Qi Z. Zhu L. Wang K. Wang N. (2023). PANoptosis: Emerging mechanisms and disease implications. Life Sciences 333 122158. https:\/\/doi.org\/10.1016\/j.lfs.2023.122158","DOI":"10.1016\/j.lfs.2023.122158"},{"key":"e_1_3_2_33_1","doi-asserted-by":"crossref","unstructured":"Renault T. T. Teijido O. Antonsson B. Dejean L. M. Manon S. (2013). Regulation of Bax mitochondrial localization by Bcl-2 and Bcl-xL: Keep your friends close but your enemies closer. International Journal of Biochemistry & Cell Biology 45(1) 64\u201367. https:\/\/doi.org\/10.1016\/j.biocel.2012.09.022","DOI":"10.1016\/j.biocel.2012.09.022"},{"key":"e_1_3_2_34_1","doi-asserted-by":"crossref","unstructured":"Seidl C. (2020). Targets for therapy of bladder cancer. Seminars in Nuclear Medicine 50(2) 162\u2013170. https:\/\/doi.org\/10.1053\/j.semnuclmed.2020.02.006","DOI":"10.1053\/j.semnuclmed.2020.02.006"},{"key":"e_1_3_2_35_1","doi-asserted-by":"crossref","unstructured":"Su Z. He Y. You L. Zhang G. Chen J. Liu Z. (2024). Coupled scRNA-seq and bulk-seq reveal the role of HMMR in hepatocellular carcinoma. Frontiers in Immunology 15 1363834. https:\/\/doi.org\/10.3389\/fimmu.2024.1363834","DOI":"10.3389\/fimmu.2024.1363834"},{"key":"e_1_3_2_36_1","doi-asserted-by":"crossref","unstructured":"Sun X. Yang Y. Meng X. Li J. Liu X. Liu H. (2024). PANoptosis: Mechanisms biology and role in disease. Immunological Reviews 321(1) 246\u2013262. https:\/\/doi.org\/10.1111\/imr.13279","DOI":"10.1111\/imr.13279"},{"key":"e_1_3_2_37_1","doi-asserted-by":"crossref","unstructured":"Sun X. Zhang Y. Chen Y. Xin S. Jin L. Liu X. Ye L. (2022). In silico establishment and validation of a novel lipid metabolism-related gene signature in bladder cancer. Oxidative Medicine and Cellular Longevity 2022 3170950. https:\/\/doi.org\/10.1155\/2022\/3170950","DOI":"10.1155\/2022\/3170950"},{"key":"e_1_3_2_38_1","doi-asserted-by":"crossref","unstructured":"Thorsson V. Gibbs D. L. Brown S. D. Wolf D. Bortone D. S. Ou Yang T. H. Shmulevich I. (2018). The immune landscape of cancer. Immunity 48(4) 812\u2013830e14. https:\/\/doi.org\/10.1016\/j.immuni.2018.03.023","DOI":"10.1016\/j.immuni.2018.03.023"},{"issue":"9","key":"e_1_3_2_39_1","first-page":"5188","article-title":"Identification and validation of an immune-related gene-based prognostic index for bladder cancer","volume":"12","author":"Tian Z.","year":"2020","unstructured":"Tian Z., Meng L., Long X., Diao T., Hu M., Wang M., Wang J. (2020). Identification and validation of an immune-related gene-based prognostic index for bladder cancer. American Journal of Translational Research, 12(9), 5188\u20135204.","journal-title":"American Journal of Translational Research"},{"key":"e_1_3_2_40_1","doi-asserted-by":"crossref","unstructured":"Tower J. (2015). Programmed cell death in aging. Ageing Research Reviews 23(Pt A) 90\u2013100. https:\/\/doi.org\/10.1016\/j.arr.2015.04.002","DOI":"10.1016\/j.arr.2015.04.002"},{"key":"e_1_3_2_41_1","doi-asserted-by":"crossref","unstructured":"Wan C. Wu Q. Wang Y. Sun Y. Ji T. Gu Y. Zhong W. (2025). Machine learning-based characterization of PANoptosis-related biomarkers and immune infiltration in ulcerative colitis: A comprehensive bioinformatics analysis and experimental validation. International Immunopharmacology 151 114298. https:\/\/doi.org\/10.1016\/j.intimp.2025.114298","DOI":"10.1016\/j.intimp.2025.114298"},{"key":"e_1_3_2_42_1","doi-asserted-by":"crossref","unstructured":"Wang Y. Zhou J. Zhang N. Zhu Y. Zhong Y. Wang Z. Wang X. (2023). A novel defined PANoptosis-related miRNA signature for predicting the prognosis and immune characteristics in clear cell renal cell carcinoma. International Journal of Molecular Sciences 24(11). https:\/\/doi.org\/10.3390\/ijms24119392","DOI":"10.3390\/ijms24119392"},{"key":"e_1_3_2_43_1","doi-asserted-by":"crossref","unstructured":"Wu B. Zhang B. Li B. Wu H. Jiang M. (2024). Cold and hot tumors: From molecular mechanisms to targeted therapy. Signal Transduction and Targeted Therapy 9(1) 274. https:\/\/doi.org\/10.1038\/s41392-024-01979-x","DOI":"10.1038\/s41392-024-01979-x"},{"key":"e_1_3_2_44_1","doi-asserted-by":"crossref","unstructured":"Xiao J. H. Xu L. Z. Ning J. Z. Cheng F. (2025). Unveiling ADAMTS12: A key driver of bladder cancer progression via COL3A1-mediated activation of the FAK\/PI3K\/AKT signaling pathway. Journal of Biological Chemistry 301(2) 108155. https:\/\/doi.org\/10.1016\/j.jbc.2025.108155","DOI":"10.1016\/j.jbc.2025.108155"},{"key":"e_1_3_2_45_1","doi-asserted-by":"crossref","unstructured":"Xiong Y. (2023). The emerging role of PANoptosis in cancer treatment. Biomedicine & Pharmacotherapy 168 115696. https:\/\/doi.org\/10.1016\/j.biopha.2023.115696","DOI":"10.1016\/j.biopha.2023.115696"},{"key":"e_1_3_2_46_1","doi-asserted-by":"crossref","unstructured":"Yao Z. Zhang H. Zhang X. Zhang Z. Jie J. Xie K. Tan W. (2022). Identification of tumor microenvironment-related signature for predicting prognosis and immunotherapy response in patients with bladder cancer. Frontiers in Genetics 13 923768. https:\/\/doi.org\/10.3389\/fgene.2022.923768","DOI":"10.3389\/fgene.2022.923768"},{"key":"e_1_3_2_47_1","doi-asserted-by":"crossref","unstructured":"Yu A. Hu J. Fu L. Huang G. Deng D. Zhang M. Luo J. (2023). Bladder cancer intrinsic LRFN2 drives anticancer immunotherapy resistance by attenuating CD8+ T-cell infiltration and functional transition. Journal for Immunotherapy of Cancer 11(10). https:\/\/doi.org\/10.1136\/jitc-2023-007230","DOI":"10.1136\/jitc-2023-007230"},{"key":"e_1_3_2_48_1","doi-asserted-by":"crossref","unstructured":"Yuan J. Ofengeim D. (2024). A guide to cell death pathways. Nature Reviews Molecular Cell Biology 25(5) 379\u2013395. https:\/\/doi.org\/10.1038\/s41580-023-00689-6","DOI":"10.1038\/s41580-023-00689-6"},{"key":"e_1_3_2_49_1","doi-asserted-by":"crossref","unstructured":"Zhang L. Zhang X. Guan M. Zeng J. Yu F. Lai F. (2024). Identification of a novel ADCC-related gene signature for predicting prognosis and therapy response in lung adenocarcinoma. Inflammation Research 73(5) 841\u2013866. https:\/\/doi.org\/10.1007\/s00011-024-01871-y","DOI":"10.1007\/s00011-024-01871-y"},{"key":"e_1_3_2_50_1","doi-asserted-by":"crossref","unstructured":"Zhou L. Lyu J. Liu F. Su Y. Feng L. Zhang X. (2024). Immunogenic PANoptosis-initiated cancer sono-immune re-editing nanotherapy by iteratively boosting cancer immunity cycle. Advanced Materials 36(2) e2305361. https:\/\/doi.org\/10.1002\/adma.202305361","DOI":"10.1002\/adma.202305361"},{"key":"e_1_3_2_51_1","doi-asserted-by":"crossref","unstructured":"Zhu J. Huang Q. Peng X. Luo C. Liu Z. Liu D. Cheng X. (2023). Identification of molecular subtypes based on PANoptosis-related genes and construction of a signature for predicting prognosis and response to immunotherapy in hepatocellular carcinoma. Frontiers in Immunology 14 1218661. https:\/\/doi.org\/10.3389\/fimmu.2023.1218661","DOI":"10.3389\/fimmu.2023.1218661"},{"key":"e_1_3_2_52_1","doi-asserted-by":"crossref","unstructured":"Zhu P. Ke Z. R. Chen J. X. Li S. J. Ma T. L. Fan X. L. (2023). Advances in mechanism and regulation of PANoptosis: Prospects in disease treatment. Frontiers in Immunology 14 1120034. https:\/\/doi.org\/10.3389\/fimmu.2023.1120034","DOI":"10.3389\/fimmu.2023.1120034"}],"container-title":["American Journal of Men's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15579883251404985","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/15579883251404985","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15579883251404985","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:28:23Z","timestamp":1777505303000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/15579883251404985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1177\/15579883251404985"],"URL":"https:\/\/doi.org\/10.1177\/15579883251404985","relation":{},"ISSN":["1557-9883","1557-9891"],"issn-type":[{"value":"1557-9883","type":"print"},{"value":"1557-9891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11]]},"article-number":"15579883251404985"}}